公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study | CHIH-HUNG HSU ; Kang Y.K.; Yang T.-S.; CHIA-TUNG SHUN ; YU-YUN SHAO ; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU ; ANN-LII CHENG | Oncology (Switzerland) | 40 | 41 | |
2009 | Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway | Chen K.-F.; Yeh P.-Y.; CHIUN HSU ; CHIH-HUNG HSU ; YEN-SHEN LU ; Hsieh H.-P.; PEI-JER CHEN ; ANN-LII CHENG | Journal of Biological Chemistry | 89 | 84 | |
2010 | Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B | BOR-SHENG KO ; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; CHIUN HSU ; Ying-Chun Shen ; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y. | Life Sciences | 40 | 36 | |
2023 | Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study | Qin, Shukui; Chan, Stephen L; Gu, Shanzhi; Bai, Yuxian; Ren, Zhenggang; Lin, Xiaoyan; Chen, Zhendong; Jia, Weidong; Jin, Yongdong; Guo, Yabing; Hu, Xiaohua; Meng, Zhiqiang; Liang, Jun; Cheng, Ying; Xiong, Jianping; Ren, Hong; Yang, Fang; Li, Wei; Chen, Yajin; Zeng, Yong; Sultanbaev, Alexander; Pazgan-Simon, Monika; Pisetska, Margaryta; Melisi, Davide; Ponomarenko, Dmitriy; Osypchuk, Yurii; Sinielnikov, Ivan; Yang, Tsai-Sheng; Liang, Xiao; Chen, Chunxia; Wang, Linna; ANN-LII CHENG ; Kaseb, Ahmed; Vogel, Arndt; CHIUN HSU | Lancet (London, England) | 71 | 16 | |
2022 | Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma | SHIH-HUNG YANG ; JEN-CHIEH LEE ; BANG-BIN CHEN ; SUNG-HSIN KUO ; CHIUN HSU ; Bai, Li-Yuan | Frontiers in Immunology | 0 | 0 | |
2006 | CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma | Su M.-C.; CHIUN HSU ; Kao H.-L.; YUNG-MING JENG | Cancer letters | 48 | 45 | |
2020 | Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma | ANN-LII CHENG ; CHIUN HSU ; Chan S.L.; Choo S.-P.; Kudo M. | Journal of Hepatology | 306 | 267 | |
2000 | Chemotherapy alone versus, surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach | Liu H.-T.; CHIUN HSU ; Chen C.-L.; Chiang I.-P.; Chen L.-T.; YAO-CHANG CHEN ; ANN-LII CHENG | American Journal of Hematology | 34 | | |
2014 | Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study | CHIUN HSU ; Tsou H.-H.; Lin S.-J.; Wang M.-C.; MING YAO ; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; HWEI-FANG TIEN ; Liu T.-W.; PEI-JER CHEN ; ANN-LII CHENG | Hepatology | 228 | 210 | |
2014 | Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers | HSIANG-FONG KAO ; I-CHUN CHEN ; CHIUN HSU ; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN ; Hu F.-C.; CHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH | Supportive Care in Cancer | 10 | 10 | |
1998 | Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer | ANN-LII CHENG ; KUN-HUEI YEH ; Lin J.-T.; CHIUN HSU ; Liu M.-Y. | Anticancer Research | 23 | 20 | |
2010 | Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma | Whang-Peng J.; ANN-LII CHENG ; CHIUN HSU ; Chen C.-M. | Journal of Experimental and Clinical Medicine | 25 | 0 | |
2014 | Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan | YU-TING CHANG ; MING-CHU CHANG ; KAI-WEN HUANG ; CHIEN-CHIH TUNG ; CHIUN HSU ; Wong J.-M. | Journal of Gastroenterology and Hepatology (Australia) | 29 | 28 | |
2023 | Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study | CHIUN HSU ; Chang, Yi-Fang; Yen, Chia-Jui; Xu, Yu-Wei; Dong, Min; Tong, You-Zhi | BMC medicine | 1 | | |
2012 | Comparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence | Yang T.-H.; DA-LIANG OU ; CHIUN HSU ; Huang S.-H.; Chang P.-L. | Electrophoresis | 17 | 17 | |
2018 | Comparative safety of immune checkpoint inhibitors in cancer: Systematic review and network meta-analysis | Xu C.; Chen Y.-P.; Du X.-J.; Liu J.-Q.; Huang C.-L.; Chen L.; Zhou G.-Q.; Li W.-F.; Mao Y.-P.; CHIUN HSU ; Liu Q.; Lin A.-H.; Tang L.-L.; Sun Y.; Ma J. | BMJ (Online) | 360 | 306 | |
2014 | Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies | BANG-BIN CHEN ; I-LUN SHIH ; CHIH-HORNG WU ; CHIUN HSU ; CHIEN-HUNG CHEN ; TIFFANY TING-FANG SHIH ; KAO-LANG LIU ; PO-CHIN LIANG | Journal of Vascular and Interventional Radiology | 10 | 8 | |
2008 | Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies | TAI-CHUNG HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; CHIUN HSU ; Chen, Chien-Yuan ; WOEI TSAY ; SHANG-YI HUANG ; MING YAO ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; HWEI-FANG TIEN | Leukemia | 47 | 42 | |
2001 | Comparison of MALT and non-MALT primary large cell lymphoma of the stomach: Does histologic evidence of MALT affect chemotherapy response? | CHIUN HSU ; Chen C.-L.; Chen L.-T.; Liu H.-T.; YAO-CHANG CHEN ; Jan C.-M.; Liu C.-S.; ANN-LII CHENG | Cancer | 14 | | |
2015 | Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014) | CHIUN HSU ; BANG-BIN CHEN ; CHIEN-HUNG CHEN ; MING-CHIH HO ; CHIA-HSIEN CHENG ; Kokudo N.; Murakami T.; Yeo W.; Seong J.; Jia J.-D.; Han K.-H.; ANN-LII CHENG | Liver Cancer | 17 | 22 | |